BSE Live
Dec 24, 16:01Prev. Close
5593.95
Open Price
5575.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 24, 15:57Prev. Close
5597.00
Open Price
5570.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Alkem Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 3,214.12 | 2,688.64 | 2,305.51 | 1,947.36 | 1,647.40 | |
| Less: Excise/Sevice Tax/Other Levies | 116.51 | 105.22 | 80.16 | 55.44 | 36.65 | |
| Revenue From Operations [Net] | 3,097.61 | 2,583.42 | 2,225.35 | 1,891.92 | 1,610.75 | |
| Total Operating Revenues | 3,182.93 | 2,672.90 | 2,300.91 | 1,929.00 | 1,633.99 | |
| Other Income | 182.13 | 166.68 | 168.10 | 135.01 | 111.03 | |
| Total Revenue | 3,365.06 | 2,839.58 | 2,469.01 | 2,064.01 | 1,745.02 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 854.11 | 751.40 | 648.34 | 586.33 | 515.00 | |
| Purchase Of Stock-In Trade | 556.35 | 435.84 | 375.31 | 258.79 | 193.99 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -11.62 | -42.69 | -121.19 | -70.79 | 3.42 | |
| Employee Benefit Expenses | 552.20 | 453.56 | 368.41 | 275.84 | 251.66 | |
| Finance Costs | 72.63 | 84.27 | 79.22 | 53.47 | 37.39 | |
| Depreciation And Amortisation Expenses | 59.68 | 42.73 | 36.02 | 27.94 | 27.05 | |
| Other Expenses | 820.16 | 678.26 | 600.92 | 472.73 | 359.17 | |
| Total Expenses | 2,903.51 | 2,403.37 | 1,987.03 | 1,604.31 | 1,387.68 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 461.55 | 436.21 | 481.98 | 459.70 | 357.34 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 461.55 | 436.21 | 481.98 | 459.70 | 357.34 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.71 | 17.16 | 32.75 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 22.71 | -3.99 | 14.49 | 10.73 | 2.65 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 22.71 | -3.99 | 15.20 | 27.89 | 35.40 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 438.84 | 440.20 | 466.78 | 431.81 | 321.94 | |
| Profit/Loss From Continuing Operations | 438.84 | 440.20 | 466.78 | 431.81 | 321.94 | |
| Profit/Loss For The Period | 438.84 | 440.20 | 466.78 | 431.81 | 321.94 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 36.70 | 36.80 | 39.00 | 36.10 | 26.90 | |
| Diluted EPS (Rs.) | 36.70 | 36.80 | 39.00 | 36.10 | 26.90 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 139.54 | 109.05 | 70.63 | 56.12 | 33.79 | |
| Indigenous Raw Materials | 477.09 | 432.18 | 392.19 | 348.20 | 353.92 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 10.73 | 4.02 | 4.68 | 3.70 | 0.56 | |
| Indigenous Stores And Spares | 31.13 | 32.67 | 32.31 | 27.38 | 21.79 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 47.83 | 23.92 | 23.91 | 23.91 | 17.93 | |
| Tax On Dividend | 8.84 | 4.06 | 3.88 | 3.88 | 2.98 | |
| Equity Dividend Rate (%) | 200.00 | 200.00 | 200.00 | 200.00 | 150.00 |
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key